| 16th Oct 2009 1:32 pm |
BUS |
Pfizer Commences Consent Solicitation for Amendments to Wyeth Indenture |
| 16th Oct 2009 7:00 am |
BUS |
Pfizer And Wyeth Become One: Working Together For A Healthier World™ |
| 15th Oct 2009 5:01 pm |
BUS |
Pfizer Completes Acquisition Of Wyeth |
| 14th Oct 2009 5:54 pm |
BUS |
Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition |
| 14th Oct 2009 12:52 pm |
BUS |
Pfizer Announces Settlement And License Agreement With Mylan Related To Vfend® |
| 9th Oct 2009 7:00 am |
BUS |
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time |
| 30th Sep 2009 9:26 am |
BUS |
Pfizer Receives Approval From Australian Competition And Consumer Commission (ACCC) For Pending Acquisition Of Wyeth |
| 29th Sep 2009 1:58 pm |
BUS |
Pfizer Receives Approval from China's Ministry of Commerce for Pending Wyeth Acquisition |
| 24th Sep 2009 1:35 pm |
BUS |
Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In Non-Small Cell Lung Cancer Patients With Specific Gene Mutation |
| 22nd Sep 2009 12:00 pm |
BUS |
Survival Benefit Maintained in Long Term Follow-up of IES with Pfizer's AROMASIN® (Exemestane Tablets) |
| 22nd Sep 2009 7:00 am |
BUS |
Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim |
| 21st Sep 2009 7:00 am |
BUS |
Pfizer To Present Research On Established Therapies And New Approaches To Cancer Treatment Using Investigational Agents |
| 2nd Sep 2009 3:33 pm |
BUS |
Pfizer Concludes Previously Disclosed Settlement Agreement With U.S. Department Of Justice Regarding Past Promotional Practices |
| 1st Sep 2009 7:30 am |
BUS |
Novel Biomarkers, Including CRP, Did Not Predict Risk Of Cardiovascular Events In Patients With Heart Disease Who Were Treated With A Statin |
| 30th Jul 2009 4:03 pm |
BUS |
Pfizer, Kano State Reach Settlement Of Trovan Cases |
| 30th Jul 2009 1:30 pm |
BUS |
Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients With Huntington Disease |
| 29th Jul 2009 4:00 pm |
BUS |
Pfizer and Fudan University Announce Joint Graduate Program in Clinical Research |
| 29th Jul 2009 3:04 pm |
BUS |
Pfizer Announces Partnership With Shanghai Institutes For Biological Sciences For Drug Discovery Activities |
| 24th Jul 2009 11:44 am |
RNS |
Election of Home Member State |
| 22nd Jul 2009 12:00 pm |
BUS |
Pfizer Reports Second-Quarter 2009 Results; Increases Full-Year 2009 Adjusted Diluted EPS(1) Guidance |
| 21st Jul 2009 10:30 am |
BUS |
96-Week MERIT ES Analysis Shows Efficacy Of Pfizer's HIV/AIDS Treatment Celsentri/Selzentry (Maraviroc) In Treatment-Naïve HIV Patients; Results Consistent With 48-Week Analysis |
| 20th Jul 2009 7:00 am |
BUS |
Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth |
| 15th Jul 2009 2:38 pm |
BUS |
Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer's Disease At ICAD Annual Meeting |
| 10th Jul 2009 7:00 am |
BUS |
Pfizer To Appeal Canadian Federal Court Decision On Company's Norvasc® Patent |
| 9th Jul 2009 3:00 pm |
RNS |
Merger Update |
| 1st Jul 2009 5:23 pm |
BUS |
Pfizer Updates CHANTIX ® (varenicline) Labeling in the United States |
| 1st Jul 2009 7:00 am |
BUS |
Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer |
| 26th Jun 2009 7:00 am |
BUS |
Pfizer Declares a 16-Cent Third-Quarter 2009 Dividend |
| 25th Jun 2009 1:00 pm |
BUS |
Sutent Significantly Improved Progression-Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors |
| 18th Jun 2009 2:12 pm |
BUS |
Pfizer Registration Statement Relating To Pending Wyeth Acquisition Declared Effective By SEC |
| 11th Jun 2009 1:29 pm |
BUS |
Pfizer's Oral JAK-3 Inhibitor Demonstrates Statistically Significant Response For Patients with Rheumatoid Arthritis, New Phase 2 Studies Show |
| 3rd Jun 2009 2:44 pm |
BUS |
FDA Approves First Canine Cancer Therapy |
| 3rd Jun 2009 1:33 pm |
BUS |
Pfizer Announces Completion Of European Debt Offering |
| 2nd Jun 2009 1:30 pm |
BUS |
Pfizer Introduces New Treatment And Support Plan For Patients With Overactive Bladder |
| 2nd Jun 2009 7:00 am |
BUS |
Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer |
| 1st Jun 2009 7:00 am |
BUS |
Pfizer Data Identify Certain Lung Cancer Patients Who May Benefit from Treatment with Figitumumab |
| 1st Jun 2009 7:00 am |
BUS |
Pfizer Presents Data With Novel Investigational Agents In Select Patient Groups With Non-Small Cell Lung Cancer |
| 29th May 2009 5:18 pm |
BUS |
New Pfizer Data Helps to Identify Kidney Cancer Patients Who May Be Most Likely to Benefit from Treatment |
| 28th May 2009 7:00 am |
BUS |
Pfizer's Sutent is Recommended for Reimbursement for Gastrointestinal Stromal Tumor Patients by British Health Agency |
| 27th May 2009 3:00 pm |
RNS |
Merger Update |
